An Immunotherapy To Treat Brain Cancer Rises In The Wake Of A Public Loss

June 2, 2015

Word of Beau Biden, Jr.’s death stunned the nation. It was a sudden loss, unexpected news that chimed and buzzed over smartphones everywhere and then flashed over television screens across the country.

Continue Reading

Analyst Interview: As Cancer Immunotherapy Turns 125, WBB Securities’ Steve Brozak Ponders What Investors Can Expect from Biotech Next

May 27, 2015

Steve Brozak sees a bubble getting larger, and he is anticipating the time when biotech stocks pull back to take a breather, like all high-flying markets ultimately do.

Continue Reading

WBB Securities Acts as Financial Advisor on $60 Million Loan for Navidea Biopharmaceuticals

May 11, 2015

WBB Securities acted as financial advisor to Navidea Biopharmaceuticals regarding a term loan with CRG (formerly Capital Royalty LP). Under the terms of the agreement, CRG will provide Navidea with initial funding of $50 million.

Continue Reading

WBB Securities Acts as Placement Agent for up to $25 Million in Equity Financing for Cytori Therapeutics

May 8, 2015

WBB Securities acted as placement agent to a transaction for Cytori Therapeutics, a clinical-stage biopharmaceutical company focused on discovering and developing autologous cell therapies from adipose tissue to treat a variety of medical conditions.

Continue Reading

WBB Securities Co-Manages $25 Million Public Offering for TetraLogic

May 1, 2015

WBB Securities is acting as co-manager to a transaction for TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics in oncology.

Continue Reading

M&A Mania Infects Generic Drug Companies

April 22, 2015

There are very few assurances in life, but in the field of generic pharmaceuticals, there are three certainties we are about to witness

Continue Reading

Can The Apple Watch Really Keep The Doctor Away?

April 9, 2015

At a little after 12:00 AM Pacific Time consumers will be able to pre-order the Apple Watch online for delivery on April 24th.

Continue Reading

The Three Things Ken Burns Gets Wrong About Cancer

April 3, 2015

Rather than focusing on the noble quest of a few scientists and physicians, we must face the reality that cancer is a business.

Continue Reading

WBB Securities Sponsors BioCentury’s Future Leaders in the Biotech Industry Conference

March 20, 2015

Today WBB Securities sponsored BioCentury’s Future Leaders in the Biotech Industry conference held at the Millennium Broadway Hotel and Conference Center in New York City.

Continue Reading

Nightmare Bacteria And Dirty Scopes: Ignorance And Want In Medicine

February 20, 2015

A deadly strain of antibiotic-resistant bacteria, dubbed “nightmare bacteria” by the head of the Centers for Disease Control and Prevention (CDC), has struck again.

Continue Reading